Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8184)
All Articles published online
|
Publishing Process of This Article
|
May 10, 2014 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Christodoulatos GS, Dalamaga M. Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis? World J Clin Oncol 2014; 5(2): 71-81 [PMID: 24829853 DOI: 10.5306/wjco.v5.i2.71] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i2/71.htm |
| Number | Citing Articles |
| 1 |
Wei Zhao, Chang-You Yin, Jing Jiang, Wei Kong, Hao Xu, Hongtao Zhang. MicroRNA-153 suppresses cell invasion by targeting SNAI1 and predicts patient prognosis in glioma. Oncology Letters 2018; doi: 10.3892/ol.2018.9706
|
| 2 |
Steven L. Wood, Janet E. Brown. Personal Medicine and Bone Metastases: Biomarkers, Micro-RNAs and Bone Metastases. Cancers 2020; 12(8): 2109 doi: 10.3390/cancers12082109
|
| 3 |
YING JIN, MIN ZHAO, QIAN XIE, HONGYAN ZHANG, QING WANG, QINGJIE MA. MicroRNA-338-3p functions as tumor suppressor in breast cancer by targeting SOX4. International Journal of Oncology 2015; 47(4): 1594 doi: 10.3892/ijo.2015.3114
|
| 4 |
Chiara de Santi, Catherine M. Greene. MicroRNAs and Other Non-Coding RNAs in Inflammation. 2015; : 3 doi: 10.1007/978-3-319-13689-9_1
|
| 5 |
Nihad Al-Othman, Ala’ Alhendi, Manal Ihbaisha, Myassar Barahmeh, Moath Alqaraleh, Bayan Z. Al-Momany. Role of CD44 in breast cancer. Breast Disease 2020; 39(1): 1 doi: 10.3233/BD-190409
|
| 6 |
Chun-yao Li, Dan-dan Xiong, Chun-qin Huang, Rong-quan He, Hai-wei Liang, Deng-hua Pan, Han-lin Wang, Yi-wen Wang, Hua-wei Zhu, Gang Chen. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics. Medical Science Monitor 2017; 23: 1857 doi: 10.12659/MSM.900030
|
| 7 |
Richard Ming Chuan Yu, Yoke Kqueen Cheah. The roles of miRNAs in human breast cancer and canine mammary tumor. Applied Cancer Research 2017; 37(1) doi: 10.1186/s41241-017-0043-7
|
| 8 |
Lihong Wang, Wen Wang, Yuanyuan Wu. MicroRNA‑26b acts as an antioncogene and prognostic factor in cervical cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.9965
|
| 9 |
Zainab Ahmed, Mohd. Mohsin. Nanoscale Sensors and their Applications in Biomedical Imaging. 2024; : 205 doi: 10.1007/978-981-97-3144-2_13
|
| 10 |
Bing Liu, Ming Lan, Huali Wei, Dapeng Zhang, Junmeng Liu, Jiwei Teng. Downregulated microRNA‑133a induces HUVECs injury: Potential role of the (pro) renin receptor in angiotensin�II‑dependent hypertension. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10519
|
| 11 |
Shiza Malik, Samra Khalid, Haidar Ali, Maham Khan, Faryal Mehwish, Aneela Javed, Fazal Akbar, Rumeza Hanif, Muhammad Suleman. In-silico modeling and analysis of the therapeutic potential of miRNA-7 on EGFR associated signaling network involved in breast cancer. Gene Reports 2020; 21: 100938 doi: 10.1016/j.genrep.2020.100938
|
| 12 |
Thalia Erbes, Marc Hirschfeld, Gerta Rücker, Markus Jaeger, Jasmin Boas, Severine Iborra, Sebastian Mayer, Gerald Gitsch, Elmar Stickeler. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1190-4
|
| 13 |
Geraldine Cizeron-Clairac, François Lallemand, Sophie Vacher, Rosette Lidereau, Ivan Bieche, Celine Callens. MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1505-5
|
| 14 |
Priyanka Mohan Lal, Muhammad Hamza Siddiqui, Amna Soulat, Anmol Mohan, Dev Tanush, Komal Tirath, Sandesh Raja, Muhammad Khuzzaim Khan, Adarsh Raja, Aayush Chaulagain, Usha Tejwaney. MicroRNAs as promising biomarkers and potential therapeutic agents in breast cancer management: a comprehensive review. Annals of Medicine & Surgery 2024; 86(6): 3543 doi: 10.1097/MS9.0000000000002075
|
| 15 |
Jennifer Y. Y. Kwan, Pamela Psarianos, Jeff P. Bruce, Kenneth W. Yip, Fei-Fei Liu. The complexity of microRNAs in human cancer. Journal of Radiation Research 2016; 57(S1): i106 doi: 10.1093/jrr/rrw009
|
| 16 |
Gerasimos Socrates Christodoulatos, Nikolaos Spyrou, Jona Kadillari, Sotiria Psallida, Maria Dalamaga. The Role of Adipokines in Breast Cancer: Current Evidence and Perspectives. Current Obesity Reports 2019; 8(4): 413 doi: 10.1007/s13679-019-00364-y
|
| 17 |
Claudia Cava, Antonio Colaprico, Gloria Bertoli, Gianluca Bontempi, Giancarlo Mauri, Isabella Castiglioni. How interacting pathways are regulated by miRNAs in breast cancer subtypes. BMC Bioinformatics 2016; 17(S12) doi: 10.1186/s12859-016-1196-1
|
| 18 |
Hongsheng Han, Zhenxian Zhang, Xueqin Yang, Wenfeng Yang, Chengwei Xue, Xiaoli Cao. miR‑23b suppresses lung carcinoma cell proliferation through CCNG1. Oncology Letters 2018; doi: 10.3892/ol.2018.9181
|
| 19 |
Maria Dalamaga, Gerasimos Socrates Christodoulatos. Adipocytokines, Energy Balance, and Cancer. Energy Balance and Cancer 2017; 12: 109 doi: 10.1007/978-3-319-41677-9_6
|
| 20 |
K. A. Grishina, V. A. Khaylenko, D. V. Khaylenko, A. V. Karpukhin. Role of microRNAs in breast cancer development and their potential as biomarkers. Tumors of female reproductive system 2018; 14(3): 40 doi: 10.17650/1994-4098-2018-14-3-40-47
|
| 21 |
Shantanu Girotra, Kristina Yeghiazaryan, Olga Golubnitschaja. Potential Biomarker Panels in Overall Breast Cancer Management: Advancements by Multilevel Diagnostics. Personalized Medicine 2016; 13(5): 469 doi: 10.2217/pme-2016-0020
|
| 22 |
Showkat Ahmad Bhat, Sabhiya Majid, Hilal Ahmad Wani, Samia Rashid. Diagnostic utility of epigenetics in breast cancer – A review. Cancer Treatment and Research Communications 2019; 19: 100125 doi: 10.1016/j.ctarc.2019.100125
|
| 23 |
Jun Chu. MicroRNA‑589 serves as a tumor suppressor microRNA through directly targeting metastasis‑associated protein 2 in breast cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.10548
|
| 24 |
Lei Huo, Yan Wang, Yun Gong, Savitri Krishnamurthy, Jing Wang, Lixia Diao, Chang-Gong Liu, Xiuping Liu, Feng Lin, William F Symmans, Wei Wei, Xinna Zhang, Li Sun, Ricardo H Alvarez, Naoto T Ueno, Tamer M Fouad, Kenichi Harano, Bisrat G Debeb, Yun Wu, James Reuben, Massimo Cristofanilli, Zhuang Zuo. MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer. Modern Pathology 2016; 29(4): 330 doi: 10.1038/modpathol.2016.38
|
| 25 |
Elif Demirdogen Sevinc, Gulsah Cecener, Secil Ak, Berrin Tunca, Unal Egeli, Sehsuvar Gokgoz, Sahsine Tolunay, Ismet Tasdelen. Expression and clinical significance of miRNAs that may be associated with the FHIT gene in breast cancer. Gene 2016; 590(2): 278 doi: 10.1016/j.gene.2016.05.033
|
| 26 |
Virginie Armand-Labit, Anne Pradines. Circulating cell-free microRNAs as clinical cancer biomarkers. Biomolecular Concepts 2017; 8(2): 61 doi: 10.1515/bmc-2017-0002
|
| 27 |
Imen Medimegh, Ines Omrane, Maud Privat, Nancy Uhrhummer, Hajer Ayari, Fadoua Belaiba, Farhat Benayed, Khaled Benromdhan, Sylvie Mader, Ives-Jean Bignon, Amel Benammar Elgaaied, Pranela Rameshwar. MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction with Clinical Outcome. PLoS ONE 2014; 9(11): e111877 doi: 10.1371/journal.pone.0111877
|
| 28 |
Olga Golubnitschaja, Manuel Debald, Kristina Yeghiazaryan, Walther Kuhn, Martin Pešta, Vincenzo Costigliola, Godfrey Grech. Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures. Tumor Biology 2016; 37(10): 12941 doi: 10.1007/s13277-016-5168-x
|
| 29 |
Xuan Zou, Minghui Li, Zebo Huang, Xin Zhou, Qingxie Liu, Tiansong Xia, Wei Zhu. Circulating miR-532-502 cluster derived from chromosome X as biomarkers for diagnosis of breast cancer. Gene 2020; 722: 144104 doi: 10.1016/j.gene.2019.144104
|
| 30 |
F Peng, Y Zhang, R Wang, W Zhou, Z Zhao, H Liang, L Qi, W Zhao, H Wang, C Wang, Z Guo, Y Gu. Identification of differentially expressed miRNAs in individual breast cancer patient and application in personalized medicine. Oncogenesis 2016; 5(2): e194 doi: 10.1038/oncsis.2016.4
|
| 31 |
Menha Swellam, Amal Ramadan, Enas A. El‐Hussieny, Noha M. Bakr, Naglaa M. Hassan, Mohamed Emam Sobeih, Lobna R. EzzElArab. Clinical significance of blood‐based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers. Journal of Cellular Biochemistry 2019; 120(8): 12321 doi: 10.1002/jcb.28496
|
| 32 |
Clémence Basse, Michel Arock. The increasing roles of epigenetics in breast cancer: Implications for pathogenicity, biomarkers, prevention and treatment. International Journal of Cancer 2015; 137(12): 2785 doi: 10.1002/ijc.29347
|
| 33 |
Maria Dalamaga, Gerasimos Socrates Christodoulatos, Christos S. Mantzoros. The role of extracellular and intracellular Nicotinamide phosphoribosyl-transferase in cancer: Diagnostic and therapeutic perspectives and challenges. Metabolism 2018; 82: 72 doi: 10.1016/j.metabol.2018.01.001
|
| 34 |
Dong Guo, Jia Guo, Xiang Li, Feng Guan. Enhanced motility and proliferation by miR‑10b/FUT8/p‑AKT axis in breast cancer cells. Oncology Letters 2018; doi: 10.3892/ol.2018.8891
|
| 35 |
Ting-Yu Chang, Hsin-An Chen, Ching-Feng Chiu, Yi-Wen Chang, Tsang-Chih Kuo, Po-Chun Tseng, Weu Wang, Mien-Chie Hung, Jen-Liang Su. Dicer Elicits Paclitaxel Chemosensitization and Suppresses Cancer Stemness in Breast Cancer by Repressing AXL. Cancer Research 2016; 76(13): 3916 doi: 10.1158/0008-5472.CAN-15-2555
|
| 36 |
Onder Yumrutas, Serdar Oztuzcu, Hakan Büyükhatipoglu, Ibrahim Bozgeyik, Esra Bozgeyik, Yusuf Ziya Igci, Haydar Bagis, M. Ozgur Cevik, M. Emin Kalender, Zeynep Eslik, Ahmet Arslan. The role of the UTS2 gene polymorphisms and plasma Urotensin-II levels in breast cancer. Tumor Biology 2015; 36(6): 4427 doi: 10.1007/s13277-015-3082-2
|
| 37 |
Andrew McGuire, James A. L. Brown, Michael J. Kerin. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring. Cancer and Metastasis Reviews 2015; 34(1): 145 doi: 10.1007/s10555-015-9551-7
|
| 38 |
Yuan Li, Yan Li, Changzhi Huang. Cancer and Noncoding RNAs. 2018; : 79 doi: 10.1016/B978-0-12-811022-5.00005-X
|
| 39 |
Andrew McGuire, James Brown, Carmel Malone, Ray McLaughlin, Michael Kerin. Effects of Age on the Detection and Management of Breast Cancer. Cancers 2015; 7(2): 908 doi: 10.3390/cancers7020815
|